CFO
H. LUNDBECK A/S
Equibles does not estimate personal net worth.
Jörg is recorded as CFO at H. LUNDBECK A/S. Jörg has spoken on 2 earnings calls across 1 company, most recently for H. LUNDBECK A/S on August 19, 2026. H. LUNDBECK A/S is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“Before I take you through the numbers, let me briefly put the H1 performance into a broader financial perspective. We continue to see strong underlying growth, which is supporting our strategic ambition to reallocate resources towards our highest value opportunities.”
“And please allow me a few opening remarks before we turn to our key figures. Over the past two years, we have executed within a very clear financial framework, prioritizing growth behind our strategic brands, accelerating innovation, and funding this through disciplined capital reallocation.”
H. LUNDBECK A/S
CFO
Transcript header (unverified)
H. LUNDBECK A/S
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Get Visual - Lundbeck Financial statements for the first six months of 2026
H. LUNDBECK A/S
Lundbeck Financial statements for the full year 2025
H. LUNDBECK A/S
